Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling
Byron J. Gajewski(University of Kansas Medical Center), Gaylan L. Rockswold(Hennepin County Medical Center), Robert Silbergleit(University of Michigan), Renee Martin(Medical University of South Carolina), William G. Barsan, William J. Meurer, Scott Berry(Queen's University)
Cited by 18
Related Papers
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Part 8: Post–Cardiac Arrest Care
|Circulation|2015|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818